| Serial Number | 90118411 |
| Word Mark | N |
| Filing Date | Monday, August 17, 2020 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, June 3, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of two curved lines to form a virtual "N". The line on the left, starting horizontally from right to left has a pointed beveled edge on both ends, and is curved from the bottom at approximately the 90 degree angle moving vertically towards the top and then angled down at approximately 45 degrees ending below the starting point of the second line on the right. The line on the right, starting horizontally from left to right has a pointed beveled edge on both ends, and is curved from the top at approximately the 90 degree angle moving vertically towards the bottom and then angled up at approximately 45 degrees ending below the starting point of the first line on the left. The combination of the two lines described can also be described as a broken rectangle made up of two broken lines, bending inward to form a virtual "N", all on a white background. |
| Goods and Services | Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the prevention of chronic and neuropathic pain; Pharmaceutical preparations for the treatment and prevention of chronic and neuropathic pain; Pharmaceutical preparations for the treatment of chronic and neuropathic pain; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for central nervous system and peripheral nervous system disorders; Analgesic and muscle relaxant pharmaceutical preparations; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of central nervous system and peripheral nervous system disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals |
| Goods and Services | Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research in the field of central nervous system and peripheral nervous system disorders; Research in the field of central nervous system and peripheral nervous system disorders; Clinical research in the field of central nervous system and peripheral nervous system disorders; Development of pharmaceutical preparations and medicines; Laboratory research in the field of central nervous system and peripheral nervous system disorders; Medical and scientific research in the field of central nervous system and peripheral nervous system disorders; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research consulting in the field of cosmetics; Scientific research for medical purposes in the field of central nervous system and peripheral nervous system disorders; Scientific research in the field of central nervous system and peripheral nervous system disorders; Scientific study and research in the field(s) of central nervous system and peripheral nervous system disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 18, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 18, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kannalife, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Doylestown, PA 18902 |
| Event Date | Event Description |
| Thursday, June 3, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, June 3, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, November 20, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, November 20, 2020 | NON-FINAL ACTION E-MAILED |
| Friday, November 20, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, November 13, 2020 | ASSIGNED TO EXAMINER |
| Monday, November 9, 2020 | ASSIGNED TO EXAMINER |
| Monday, November 9, 2020 | ASSIGNED TO EXAMINER |
| Thursday, September 24, 2020 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Thursday, September 24, 2020 | ASSIGNED TO LIE |
| Saturday, September 19, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, September 18, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, August 25, 2020 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Thursday, August 20, 2020 | NEW APPLICATION ENTERED IN TRAM |